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ABSTRACT
Splicing factor proline- and glutamine-rich (SFPQ) also commonly known as polypyrimidine tract-binding protein-associated-
splicing factor (PSF) and its binding partner non-POU domain-containing octamer-binding protein (NONO/p54nrb), are highly
abundant, multifunctional nuclear proteins. However, the exact role of this complex is yet to be determined. Following
purification of the endogeneous SFPQ/NONO complex, mass spectrometry analysis identified a wide range of interacting
proteins, including those involved in RNA processing, RNA splicing, and transcriptional regulation, consistent with a
multifunctional role for SFPQ/NONO. In addition, we have identified several sites of arginine methylation in SFPQ/PSF using
mass spectrometry and found that several arginines in the N-terminal domain of SFPQ/PSF are asymmetrically dimethylated.
Furthermore, we find that the protein arginine N-methyltransferase, PRMT1, catalyzes this methylation in vitro and that this is
antagonized by citrullination of SFPQ. Arginine methylation and citrullination of SFPQ/PSF does not affect complex formation
with NONO. However, arginine methylation was shown to increase the association with mRNA in mRNP complexes in
mammalian cells. Finally we show that the biochemical properties of the endogenous complex from cell lysates are
significantly influenced by the ionic strength during purification. At low ionic strength, the SFPQ/NONO complex forms large
heterogeneous protein assemblies or aggregates, preventing the purification of the SFPQ/NONO complex. The ability of the
SFPQ/NONO complex to form varying protein assemblies, in conjunction with the effect of post-translational modifications of
SFPQ modulating mRNA binding, suggests key roles affecting mRNP dynamics within the cell.
Keywords: polypyrimidine tract-binding protein-associated-splicing factor; splicing factor proline- and glutamine-rich; non-POU
domain-containing octamer-binding protein; arginine methylation; citrullination; mRNP binding; mass spectrometry
INTRODUCTION
Splicing factor, proline- and glutamine-rich (SFPQ) also
commonly known as polypyrimidine tract-binding protein-
associated-splicing factor (PSF) and its binding partner
non-POU domain-containing octamer-binding protein
(NONO/p54nrb) are highly abundant, multifunctional nu-
clear proteins (Shav-Tal and Zipori 2002). SFPQ/PSF com-
prises an N-terminal glycine rich domain (containing three
RGG repeats), a proline/glutamine-rich domain (P/Q), two
RNA recognition motifs (RRMs), and a C-terminal region
with two nuclear localization signals (Patton et al. 1991).
NONO/p54nrb is homologous to the C-terminus of SFPQ/
PSF (Shav-Tal and Zipori 2002) and has been shown to asso-
ciate with SFPQ/PSF (Zhang et al. 1993; Straub et al. 1998;
Peng et al. 2002; Shav-Tal andZipori 2002;Hanna et al. 2006).
SFPQ and NONO have been identified in proteomic stud-
ies of the spliceosome and in splicing-related complexes
(Rappsilber et al. 2002; Peng et al. 2006). Furthermore, in
the absence of SFPQ/PSF, spliceosome formation (complexes
A and B) is severely impaired (Patton et al. 1993). SFPQ/PSF
binds PTB/hnRNPI which interacts with the polypyrimidine
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tract of intronic mRNA, a region important in the definition
of the 3′-splice site inmammalian cells (Patton et al. 1993). In
contrast, NONO is not required for spliceosome assembly or
splicing (Zhang and Wu 1996). However, it has been shown
to interact with important components of the spliceosome
such as U5 snRNA and the 5′-splice site (Peng et al. 2002;
Kameoka et al. 2004). NONO was also shown to increase
the efficiency of splicing in vitro (Zhang andWu 1996). Con-
sistent with the coupling of transcription and splicing (Ro-
sonina et al. 2005) this complex additionally interacts with
the C-terminal domain of RNAPII (Hirose and Manley
2000; Emili et al. 2002). Moreover, NONO binds to the 5′-
splice sites in a complex with both splicing and transcription
factors (Emili et al. 2002; Kameoka et al. 2004).
Further to their spliceosome-related functions, SFPQ/
NONO has been implicated in a wide variety of regulatory
roles including the selective nuclear retention of defective
mRNAs (Zhang and Carmichael 2001). More recently,
SFPQ/NONO were shown to be stimulatory factors for U
snRNA export (Izumi et al. 2014) and DNA topoisomerase
I (Straub et al. 1998, 2000) together with a role in the nonho-
mologous end joining response to DNA double strand breaks
(Bladen et al. 2005). SFPQ also acts as a transcriptional reg-
ulator recruiting Sin3a, which in turn recruits histone deace-
tylase (HDAC) thus repressing transcription (Mathur et al.
2001; Sewer et al. 2002; Dong et al. 2007). Similarly a PER
complex that rhythmically associates with DNA bound
CLOCK-BMAL1 at the Per1 promoter represses trans-
cription by virtue of its constituent SFPQ which recruits
the SIN3-HDAC complex to deacetylate histones 3 and 4
(Duong et al. 2011). Conversely, in the case of androgen re-
ceptor responsive genes, transcriptional activation by SFPQ/
NONO has been demonstrated (Ishitani et al. 2003; Kuwa-
hara et al. 2006). Further examples of the functional diversity
of SFPQ and NONO are their involvement in developmen-
tally linked gene regulation, specifically, in relation to neuro-
nal tissue development (Chanas-Sacré et al. 1999; Ju et al.
2004) and cell cycle control (Stier et al. 2005).
Protein arginine N-methyltransferases (PRMTs) catalyze
the post-translational transfer of a methyl group from the
donor S-adensoyl-L-methioinine (AdoMet) to arginine resi-
dues (Bedford and Richard 2005; Bedford and Clark 2009).
Three forms of arginine methylation have been described
NG monomethylarginine, NGNG dimethylarginine (asym-
metric dimethylarginine aDMA), and NGN′G dimethylargi-
nine (symmetric dimethylarginine sDMA). Protein arginine
methylation is known to play a role in regulating trans-
cription, RNA splicing, and in RNA/protein import/export
from the nucleus. Arginine residues are also targeted for an
additional type of post-translational modification, which re-
sults in conversion to the noncoded amino acid citrulline
(Vossenaar et al. 2003). This deimination of arginine is cata-
lyzed by a family of peptidyl arginine deiminases (PADIs or
PADs) and results in the loss of a positive charge. This con-
version is antagonistic with respect to arginine methylation
since deiminated arginine residues cannot be methylated
and arginine methylation blocks its own citrullination.
Currently, the best understood biological role for this antag-
onism is in the regulation of chromatin structure. For exam-
ple, PADI4 catalyzed deimination of histone H3 at Arg17 and
histone H4 at Arg 3 has been linked to transcriptional repres-
sion (Cuthbert et al. 2004; Wang et al. 2004). Conversely, cit-
rullination of histone H3R26 by PADI2 has been shown to
facilitate transcriptional activation at target genes (Zhang et
al. 2012). More recently, Christophorou et al. (2014) have
demonstrated that citrullination of histone H1 leads to chro-
matin decondensation during pluripotency.
Many proteins involved in mRNP biogenesis have been
shown to be arginine methylated (Liu and Dreyfuss 1995;
Yu et al. 2011). The post-translational modification of
mRNP components is likely tomodulate either the rate or ex-
tent of their interactions necessary for the ordered assembly
of mRNPs and the associated coupling of transcription with
mRNA processing. However, in many cases, it remains to
be determined how methylated arginines influence the mo-
lecular activities of RNA-binding proteins. Here, we show
in mammalian cells that arginine methylation of SFPQ/
PSF does not affect the binding of its interacting partner
NONO. However, arginine methylation is shown to enhance
the interaction between SFPQ/PSF and mRNA.
RESULTS AND DISCUSSION
Mass spectrometry analysis of the
SFPQ/NONO complex
NONO contains an N-terminal histidine rich sequence, en-
abling purification of the SFPQ/NONO complex from
HeLa nuclear extracts (see Fig. 1A) and additional cell lines
(see Fig. 1B) using immobilized metal ion affinity chroma-
tography (IMAC) by Ni-NTA open tube capillaries (Ni-
NTA PhyCap OTCs) (Hanna et al. 2006; Qureshi et al.
2013). SDS-PAGE analysis of eluted material shows two ma-
jor proteins captured from the affinity enrichment, that were
unambiguously identified as SFPQ and NONO using mass
spectrometry (MS). No enrichment of the complex was ob-
served in the absence of Ni2+ and NTA (see Fig. 1A) demon-
strating specificity of the IMAC purification. Subsequent MS
analysis identified ∼50 coeluting proteins from the Ni-NTA
PhyCap OTCs which are listed in Supplemental Table S1, re-
flecting the multifunctional role of the SFPQ/NONO com-
plex within the cell. An overview of the categorization of
proteins based on their functional annotation is shown in
Figure 1C and highlights an enrichment for proteins thought
to be involved in RNA processing, RNA splicing and tran-
scriptional regulation. Proteins with His-rich motifs were
also screened, as they may copurify on the Ni-NTA PhyCap
OTC (see Fig. 1C; Supplemental Table S1).
SFPQ and NONO are knownmembers of the spliceosome
and have previously been identified in a large scale antibody-
Snijders et al.
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FIGURE 1. Purification and characterization of the SFPQ/NONO complex. (A) Enrichment of the SFPQ/NONO complex from HeLa nuclear cell
extracts using Ni-NTA PhyCap OTC including the absence of Ni2+ and NTA. (B) Ni-NTA PhyCap OTC enrichment of the SFPQ/NONO complex
from different cell extracts. Purified complexes were analyzed on SDS-PAGE stained with Coomassie blue. (C) Functional categorization of proteins
identified using mass spectrometry analysis of the SFPQ/NONO complex purified using Ni-NTA PhyCap OTCs. (D) Effect of salt concentration on
the SFPQ/NONO interaction. Ni-NTA PhyCap OTC enrichment of the SFPQ/NONO complex was performed over a range of NaCl concentrations
highlighted. (E) Effect of splicing conditions on the SFPQ/NONO interaction. Ni-NTA PhyCap OTC enrichment of the SFPQ/NONO complex was
performed under both splicing and nonsplicing conditions as shown. (F) Repurification of the SFPQ/NONO complex under low salt conditions (6
mM NaCl). (G) Chemical crosslinking of the SFPQ/NONO complex. Following chemical crosslinking the complex was analyzed using SDS-PAGE
stained with Coomassie blue.
Arginine methylation of SFPQ
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based proteomic analysis (Rappsilber et al. 2002; Peng et al.
2006). A comparison of the proteins identified in these stud-
ies with data presented here, reveals a significant corrobora-
tion (see Supplemental Table S1). In addition, a number of
proteins were identified that were unique to this study in-
cluding paraspeckle protein 1 (PSPC1), symplekin, FIP1,
and nucleophosmin. PSPC1 is a component of a novel sub-
nuclear compartment named paraspeckle and was previously
shown to interact with NONO via its coiled-coil domain (Fox
et al. 2005). PSPC1 and SFPQ and have also been shown to
be coexpressed and interact with Sertoli cells (Kuwahara
et al. 2006). Structural studies have shown that PSPC1 and
NONO form an extensively intertwined dimer (Passon et
al. 2012).
Symplekin and FIP1 are both involved in polyadenylation
(Takagaki and Manley 2000) and FIP1 also interacts with the
polypyrimidine tract binding protein (PTB), a known bind-
ing partner of SFPQ (Patton et al. 1993; Zhao et al. 2005).
pre-mRNA cleavage factor 68 kDa was also identified and
has previously been identified with partial paraspeckle local-
ization (Dettwiler et al. 2004). Another protein, a 68-kDa
pre-mRNA cleavage factor previously identified with partial
paraspeckle localization (Dettwiler et al. 2004) was also de-
tected in this analysis. Nucleophosmin is a ubiquitous and
multifunctional protein involved in ribosome biogenesis,
centrosome duplication, and cell signaling. Our identifica-
tion of a Ser/Thr phosphatase regulatory subunit, an inhibi-
tor of the α- and γ-isoforms of protein phosphatase (Kreivi
et al. 1997) is relevant since another protein phosphatase
(1-δ) is known to interact with SFPQ (Hirano et al. 1996).
Also relevant to regulation by phosphorylation/dephosphor-
ylation, a component of the ubiquitous cAMP-dependent
protein kinase was detected.
Ionic strength alters the SFPQ/NONO
complex
The influence of ionic strength upon the purification of the
SFPQ/NONO complex fromHeLa cell lysates was performed
by incorporating NaCl concentrations between 0 and 1 M in
the binding, washing, and elution buffers during the Ni-NTA
PhyCap OTC enrichment procedure (Fig. 1D). The results
show that the SFPQ/NONO complex can be readily purified
over a range of ionic strength conditions (0.1–1 M NaCl), in-
dicating that the formation of the SFPQ/NONO complex re-
lies on hydrophobic interactions. Under conditions of low
ionic strength (<100 mM NaCl) a significant reduction in
the yield of the SFPQ/NONO complex is observed. Interest-
ingly, an alternative protein was purified under these con-
ditions, which was identified via MS as glyceraldehyde
3-phosphate dehydrogenase (GAPDH). These data also dem-
onstrate the relative high stability of the SFPQ/NONO com-
plex, even at elevated ionic strength conditions (1 M NaCl).
At low ionic strength (below 100 mM salt) purification of the
SFPQ/NONO complex is compromised.
The enrichment of the SFPQ/NONO complex using Ni-
NTA OTCs was also performed under typical splicing con-
ditions (60 mM KCl in the presence of additional divalent
cations, ATP, and phosphocreatinine) (Peng et al. 2006).
Under such conditions, Ni-NTA PhyCap OTC enrichments
show a reduction in the yield of purified SFPQ/NONO com-
plex (see Fig. 1E) as expected from the previous results under
low salt conditions. The splicing buffer was further altered to
test whether the presence of magnesium ions or ATP played a
significant role in the enrichment profile using the Ni-NTA
PhyCap OTCs. The results shown in Figure 1E demonstrate
that the presence of magnesium ions and ATP had negligible
impact on enrichment profiles in either splicing buffer or
PBS. These findings are consistent with those of Peng et al.
(2006) were under in vitro splicing conditions, SFPQ associ-
ates with all five splicing snRNPs as well as many other splic-
ing factors regardless of the presence of exogenous pre-
mRNA.
It is proposed that the SFPQ/NONO complex exists as
a heterodimer previously observed at high salt concentrations
(typical intracellular salt concentrations are 150 mM NaCl).
Alternatively, at low salt conditions such as those typically
used for in vitro splicing, the SFPQ/NONO complex exists
as part of larger splicing particles or more heterogeneous pro-
tein assemblies. Under these conditions, additional protein
interactions including the association of the five snRNPs
are facilitated (Peng et al. 2006). The formation of these large
heterogeneous protein assemblies precludes the binding of
NONO to the Ni-NTA surface of the open tube capillaries.
To confirm that the association of SFPQ/NONO as part of
the large heterogeneous splicing complex prevents the inter-
action with the Ni-NTA surface rather than a direct effect of
different salt conditions influencing the interaction of
NONO with the Ni-NTA PhyCap OTC, the SFPQ/NONO
complex enriched under standard conditions was subse-
quently diluted to significantly reduce the salt concentration
(to ∼6 mM NaCl) and repurified under salt-free conditions
(see Fig. 1F). These results show that the formation of the
SFPQ/NONO complex is enriched in low salt conditions in
the absence of additional splicing factors and associated pro-
teins, where formation of the larger splicing complex is
prevented.
Chemical crosslinking of the SFPQ/NONO complex
Based on the intensities of each band following Coomassie
staining of SDS-PAGE analysis of the SFPQ/NONO complex,
we conclude that a stoichiometry of 1:1 fits the observations.
To further analyze the size and stoichiometry of the complex
enriched using Ni-NTA PhyCap OTCs, the SFPQ/NONO
complex was chemically crosslinked using sulfosuccinimidyl
suberate. SDS-PAGE analysis of the crosslinked complex is
shown in Figure 1G, where a single high MW band is ob-
served, demonstrating the formation of a covalent complex
with a calculated mass of ∼250 kDa. These results are
Snijders et al.
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consistent with previous gel filtration studies of the SFPQ/
NONO complex which suggested a mass of 280 kDa, suggest-
ing that the protein is a tetramer under physiological condi-
tions (Zhang et al. 1993). A number of possible multimeric
crosslinked species are consistent with this MW including
homotetrameric SFPQ complex or a possible heterotetramer
of SFPQ (although SFPQ migrates anomalously as a 100 kDa
protein during SDS-PAGE) and NONO (54 kDa). MS anal-
ysis of the high MW crosslinked complex identified the pres-
ence of both SFPQ and NONO, therefore supporting the
formation of the SFPQ/NONO heterotetramer.
These data provide a robust evaluation of the stoichiome-
try of the interactions between SFPQ and NONO. The appli-
cation of OTCs in conjunction with MS for the analysis of
the complexes, greatly facilitates the experimental investiga-
tion of the SFPQ/NONO complex, taken together with the
cross linking data, we have developed a
platform for the analysis of regulatory
processes, which are likely to be an im-
portant feature in our dissection of the
biological role of these molecules.
Identification and characterization
of arginine methylation of SFPQ/PSF
by MS
A range ofMS approacheswere undertak-
en to comprehensively characterize and
identify sites of arginine methylation in
SFPQ including the use of both CID
and ETD in conjunction withMS analysis
(Snijders et al. 2010). In addition, heavy
methyl SILAC was also used to verify the
sites of arginine methylation in SFPQ.
Cells were grown in medium containing
heavy methionine (CD3-L-methionine),
which is converted in vivo to heavy
AdoMet, which serves as a universal
methyl-group donor in methyl transfer
reactions including arginine methylation
(Ong et al. 2004). The MS analysis of
SFPQ identified the occurrence of both
mono and dimethylation of arginine. A
summary of the sites identified is shown
in Figure 2A. MS analysis also enabled
us to differentiate between the type of ar-
ginine dimethylation present by virtue of
the characteristic neutral losses. The tan-
dem MS spectra of two arginine methyl-
ated peptides SR(aDMA)GGGGGGFHR
(heavy methyl labeled) and FR(MMA)
SR(aDMA)GGGGGGFHR are shown in
Figure 2B,C, respectively. The neutral
loss of dimethylamine is highlighted in
the spectra, confirming asymmetric
dimethylation in each case. Furthermore,
arginine methylation was observed in
SFPQ purified from a wide range of cell
lines including HEK293, U2OS, CHO,
HL60, and HeLa cells. A list of all modi-
fied peptides identified by MS is shown
in Supplemental Table S2.
A
B
C
FIGURE 2. Identification of arginine methylation of SFPQ/PSF. (A) Dimethylation (R)
and both mono or dimethylation (R) sites are mapped on the primary sequence of SFPQ.
(B) ETD MS/MS fragmentation spectra of the heavy methylated peptide SR(aDMA)
GGGGGGFHR [M+3H]3+. (C) ETD MS/MS fragmentation spectra of the heavy methylated
peptide FR(MMA)SR(aDMA)GGGGGGFHR [M+3H]3+. The prominent c, z ions and the char-
acteristic neutral losses associated with asymmetric dimethylation are highlighted (aDMA) dime-
thylamine, (MMA) monomethylarginine.
Arginine methylation of SFPQ
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PRMT1 methylates SFPQ/PSF in vitro
To further characterize the arginine methylation of SFPQ, in
vitro methylation reactions were performed on endogenous
and recombinant SFPQ using a range of protein arginine
methyltransferases (PRMTs 1, 3, 5, and 6), in the presence
of tritiated S-adenosyl-L-methionine ([3H] AdoMet). The re-
sults are shown in Figure 3A,B and demonstrate that only
PRMT1 (and to a lesser extent PRMT3) arginine methylate
SFPQ in vitro. Since PRMT3 is cytoplasmic and PRMT1 pre-
dominantly nuclear, it is likely that PRMT1 is responsible for
the methylation of SFPQ within the nucleus of mammalian
cells. Following in vitro methylation by PRMT1, further
MS analysis was performed to identify the sites and type of
arginine methylation of SFPQ in vitro. A number of sites
identified in vivo were also methylated by PRMT1 in vitro
(see Supplemental Table S2). Further-
more, methylation of SFPQ by PRMT1
is also consistentwith the identification of
asymmetric dimethylation in vivo, since
PRMT1 is a type I methyltransferase
which results in asymmetric dimethyla-
tion, in contrast to type II methyltrans-
ferases such as PRMT5 which results in
symmetric methylation (Wolf 2009).
Arginine methylation does not affect
the interaction of SFPQ/PSF with
NONO/p54nrb
To study the functional effects of argi-
nine methylation on the SFPQ/NONO
interaction, extracts were prepared from
293T cells grown in both the presence
and absence of the methylation inhibitor
adenosine dialdehyde (AdOx). Immuno-
precipitation was performed using an
antibody specific to SFPQ prior to SDS-
PAGE analysis (see Fig. 3C). The results
show that methylation of SFPQ does
not significantly affect the interaction
with NONO. We further investigated
the SFPQ/NONO interaction using co-
immunoprecipitation (Co-IP) assays.
Extracts were prepared from 293T cells
transfected with a FLAG-SFPQ expres-
sion vector, which had been incubated
both with and without the global methyl-
ation inhibitor AdOx and a selective
inhibitor of protein arginine methyl-
transferases (AMI-1). This analysis also
showed that Co-IP of FLAG-SFPQ and
NONO was not affected by arginine
methylation (see Fig. 3D). Inhibition
of methylation was confirmed by analy-
sis of total extracts which revealed a dis-
tinct electrophoretic mobility shift for
a known arginine methylated protein
Chtop (see Fig. 3E; Chang et al. 2013).
Furthermore, inhibition of methylation
was also confirmed by MS analysis of pu-
rified SFPQ, the MS being consistent
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FIGURE 3. Arginine methylation of SFPQ/PSF does not affect binding to NONO. (A,B)
Methylation assays were performed in conjunctionwith the addition of tritiated S-adenosyl-L-me-
thionine ([3H]AdoMet) to detectmethylation of (A) recombinant SFPQusing PRMT1, 3, 4, and 6
and (B) endogenous SFPQusing PRMT1. (C) Antibody enrichment of the SFPQ/NONOcomplex
using total extracts from +/− AdOx treated cells. Eluted proteins were analyzed by SDS-PAGE
stainedwithCoomassie blue. (D)Co-IPof FLAG-SFPQ in the presence ofRNAseA from293Tcells
treated with AdOx/AMI-1 as indicated. Total extract (1% of input) and eluted proteins were ana-
lyzed byWestern blotting with anti-FLAG and anti-NONO. (E) Co-IP of FLAG-SFPQ in the pres-
ence of RNAse A from 293T cells treated with AdOx as indicated. Total extract (1% of input) and
eluted proteins were analyzed byWestern blotting with anti-FLAG, anti-NONO, and anti-Chtop.
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with an overall reduction in the level of
dimethylated arginine.
Arginine methylation of SFPQ/PSF
affects mRNA binding in mammalian
cells
UV crosslinking studies were performed
to demonstrate the binding of RNA to
SFPQ in mammalian cells. Following
overexpression of FLAG-SFPQ and UV
crosslinking, immunopurified FLAG-
SFPQ under high ionic strength condi-
tions (1 MNaCl) was assayed for binding
RNA using partial RNase digestion and
end-labeling with [γ−32P]ATP and poly-
nucleotide kinase (see Fig. 4A). The
results demonstrate that following cross-
linking and purification, RNAwas specif-
ically bound to SFPQ, while no RNA was
detected in association with NONO.
FLAG-tagged ALYREF was used as a pos-
itive control showing specific binding to
RNA only following covalent cross-link-
ing by UV. To further examine the
mRNA binding activity of SFPQ inmam-
malian cells, we carried out an mRNP
capture assay in the presence and absence
of AdOx/AMI-1 (Fig. 4B).Whole-cell ex-
tracts from UV cross-linked cells treated
or not with AdOx/AMI-1 were subjected
to oligo(dT) pull down assays under
denaturing conditions in order to investi-
gate direct binding of poly(A)+ RNA
to SFPQ in mammalian cells. This analy-
sis revealed that the presence of both
AdOx/AMI-1 led to a significant reduc-
tion in SFPQ bound to mRNA than was
found in a methylated untreated control.
The mRNA capture was specific since co-
valent crosslinks were not observed in the
absence of UV exposure. Furthermore,
the results demonstrate no direct binding
of NONO tomRNA, consistent with pre-
vious UV crosslinking experiments (see Fig. 4A). Control ex-
periments verifying the reduction of methylation of Chtop
and the effect onmRNP binding are shown in Figure 4C, con-
sistent with previous observations (Chang et al. 2013).
Citrullination of SFPQ/PSF blocks in vitro methylation
To investigate whether SFPQ is a substrate for PADI4 in vitro,
recombinant SFPQ was citrullinated using overexpressed
PADI4 in the presence of calcium and analyzed by MS. The
MS analysis revealed a number of sites of citrullination in
the N-terminus of SFPQ (Supplemental Table S2). The tan-
dem MS spectra of the citrullinated peptide GGGGGCit
GGLHDFR is shown in Figure 5A. The characteristic loss of
isocyanic acid (−43 Da) from the doubly charged precursor
ion and b6 ion was used as a further diagnostic for the identi-
fication of citrullination in this peptide (Hao et al. 2009).
Owing to the difficulties associated with the MS based identi-
fication of citrullination and the discrimination of deamida-
tion of glutamine and asparagine residues (corresponding
1 Da gain), citrullination reactions were also performed in
the presence of 50% H2
18O. This approach enables confident
A
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FIGURE 4. Arginine methylation of SFPQ affects mRNA binding. (A) 293T cells cotransfected
with a FLAG control, FLAG-SFPQ, and FLAG-ALYREF were UV crosslinked and purified using
FLAG affinity beads. Eluted proteins were RNase treated and radiolabeled (32P) using PNK.
Resulting complexes were analyzed by SDS-PAGE stained with Coomassie blue (right panel)
and Phosphoimage (left panel). (B,C) mRNP capture assay. Poly(A)+ RNA from 293T cells +/−
AdOx/AMI-1 transfectedwith FLAGor FLAG-SFPQwas purified on oligo(dT) in denaturing con-
ditions after UV cross-linking (+) or not (−). Total extract (1% of input) and eluted proteins were
analyzed by Western blotting (WB) with a FLAG antibody, NONO antibody, or Chtop antibody.
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assignment of citrullination peptides
by virtue of the isotopic distribution of
the citrullinated peptides (Kubota et al.
2005). The MS spectra of the peptide
GGGGGCit GGLHDFR citrullinated in
the presence of 50% H2
18O in Figure 5B
show incorporation of the stable isotope
from the heavy water following the reac-
tion with SFPQwith PADI4, thereby con-
firming enzymatic citrullination of this
peptide. Verification of all citrullinated
peptides identified in this study was
achieved using both the characteristic
neutral loss of isocyanic acid and the iso-
topic distribution following incorpora-
tion of 50% H2
18O (see Supplemental
data). The combined MS results enabled
the identification of a number of sites of
citrullination in the N-terminus of SFPQ
by PADI4, and are summarized in
Supplemental Table S2.
It is interesting to note that all the iden-
tified sites of citrullination were also
identified as dimethlyated in endoge-
nous SFPQ. No other arginine residues
were identified as citrullinated in SFPQ,
highlighting the specific nature by which
PADI4 citrullinates SFPQ in vitro. These
findings offer the tantalizing prospect
that citrullination may block arginine
methylation of SFPQ and thus regulate
function. To determine whether arginine
methylation of SFPQ can be blocked
by citrullination in vitro, recombinant
SFPQ was first citrullinated with PADI4
in the presence of calcium ions. Following
citrullination of SFPQ (confirmed by MS
analysis), the citrullinated SFPQ was used
as a substrate for PRMT1 in the presence
of tritiated AdoMet and analyzed using
autoradiography. As shown in Figure 5C
citrullination does indeed prevent subse-
quentmethylation by PRMT1. Therefore,
citrullination has the potential to block
methylation of SFPQ in vivo and thus an-
tagonize the effects of arginine methyla-
tion. Demethylimination of arginine has
also been reported, with the majority of
in vitro demethylimination studies dem-
onstrating that dimethylated arginines
are poor substrates for PADI4. The ability
to demethyliminate endogenous methyl-
ated SFPQ was not possible as constitu-
tive methylation of SFPQ is unlikely
(verified by the additional methylation
A
C
D
E F
B
FIGURE 5. Citrullination blocks arginine methylation of SFPQ/PSF in vitro. (A) CID MS/MS
fragmentation spectra of the in vitro citrullinated peptide GGGGGCitGGLHDFR [M+2H]2+
from SFPQ. The prominent y, b ions and the characteristic neutral losses associated with isocyanic
acid are highlighted. (B) MS spectra highlighting the isotopic distribution due to the incorpora-
tion of H2
18O during the enzymatic citrullination of SFPQ using PADI4. (C) Methylation assays
were performed in conjunction with the addition of tritiated S-adenosyl-L-methionine ([3H]
AdoMet) to detect methylation of recombinant SFPQ using PRMT before and after citrullination
using PADI4. Left panel shows the autorad, right panel shows the Coomassie stained SDS-PAGE.
(D)Citrullinationof SFPQaffectsmRNAbinding. Poly(A)+RNA from293Tcells +/−AdOx trans-
fected with FLAG, FLAG-SFPQ, FLAG-SFPQ +HA PADI4/Ca2+ ionophore was purified on oligo
(dT) in denaturing conditions after UV cross-linking (+) or not (−). Total extract (1% of input)
and elutedproteinswere analyzedbyWesternblotting (WB)withα-FLAGantibody,α-ALYREF, or
Chtop antibody. (E) Co-IP of FLAG control, FLAG-SFPQ in conjunction with PADI4 in the pres-
ence of Ca2+ ionophore. Total extract (1% of input) and eluted proteins were analyzed byWestern
immunoblottingusingα-FLAG,α-NONO,α-Chtop, orα-Tubulin antibodies. (F) PADI4/Ca2+ in-
creases SFPQ/PSF abundance in mammalian cells. 293T cells were cotransfected with either a
FLAG control, FLAG-SFPQ in conjunction with PADI4 in the presence of Ca2+ ionophore and
5 mM CaCl2. Of note, 100 mM cycloheximide was added for 6 h when indicated (+) in order to
block de novo protein synthesis. Twelve percent SDS-PAGEwas analyzed usingWestern immuno-
blotting using α-FLAG, α-ALYREF, α-Chtop, or α-Tubulin antibodies.
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of endogenous SFPQ by PRMT1 in vitro). Therefore, the abil-
ity of PADI4 to demethyliminate the N-terminal asymmetr-
ic dimethylated arginine residues was analyzed using an
N-terminal peptide substrate containing the sites of aDMA
identified on SFPQ. The MS analysis revealed no demethyli-
mination upon the addition of PADI4 (data not shown, con-
sistent with previous observations, Raijmakers et al. 2007).
Citrullination of SFPQ/PSF affects mRNA binding
in mammalian cells
To examine the effects of SFPQ citrullination on mRNA
binding, we carried out an mRNP capture assay following
the coexpression of both FLAG-SFPQ and PADI4 in the pres-
ence of a calcium ionophore (Fig. 5D). This analysis revealed
that in the presence of PADI4/Ca2+ a significant reduction in
SFPQ bound to mRNA in mammalian cells was observed
compared with the methylated control. The mRNA capture
was specific since covalent crosslinks were not observed in
the absence of UV exposure. Verification of the citrullination
of SFPQ was performed using MS, and a number of sites
of citrullination were identified including those previously
identified as arginine methylated as summarized in Supple-
mental Table S2. We further investigated the SFPQ/NONO
interaction using coimmunoprecipitation (Co-IP) assays. Ex-
tracts were prepared from 293T cells transfected with a
FLAG-SFPQ and PADI4 in the presence of a calcium iono-
phore. The results showed that the Co-IP of FLAG-SFPQ
and NONO was not affected by the presence of PADI4/
Ca2+ and citrullination of SFPQ (see Fig. 5E).
PADI4 increases SFPQ/PSF abundance
in mammalian cells
Data from the Co-IP and mRNA capture assays suggested in-
creased expression of SFPQ in the presence of PADI4/Ca2+
ionophore (see Fig. 5D,E). To further investigate the stability
of SFPQ in the presence of PADI4, HEK 293T cells were
cotransfected with FLAG or FLAG-SFPQ in conjunction
with PADI4 in the presence of Ca2+ ionophore. Cyclohexi-
mide was added to block de novo protein synthesis. Western
blotting was used to detect steady-state levels of SFPQ and
control ALYREF or Chtop proteins (see Fig. 5F). The results
show that in the presence of PADI4/Ca2+, increased levels of
SFPQ were observed in both the presence and absence of cy-
cloheximide treatment. These results indicate that the protein
stability is not affected by citrullination, raising the possibility
of a mechanism based on increased transcription and/or
translation of SFPQ.
CONCLUSIONS
SFPQ and NONO are multifunctional nuclear proteins that
appear to play a role in a diverse range of key processes with-
in the cell including RNA processing, RNA splicing, and
transcriptional regulation. Here we show that a number of
N-terminal arginine residues in SFPQ are asymmetrically
dimethylated in mammalian cells, a reaction that can be cat-
alyzed by PRMT1. Arginine methylation of SFPQ leads to an
increase in its association with mRNA either via a direct effect
of methylation on RNA binding or an indirect effect on
protein–protein interactions that alters SFPQ RNA bind-
ing specificity and/or affinity. In addition to controlling
protein–protein interactions between mRNP components,
arginine methylation modulates the ability of certain RNA-
binding proteins to target their nucleic acid substrate.
Methylation of arginine has the potential to reduce hydrogen
bonding networks with RNA or it may sterically hinder the
association between the RNA and protein. Alternatively, it
has been proposed that methylation enhances the association
with RNA by rendering the arginine more hydrophobic,
thereby facilitating stacking with the RNA bases (Bedford
and Richard 2005).
Arginine methylation has been reported to modulate RNA
binding activity in a wide range of RNA binding proteins in-
cluding hnRNPA1 and Sam68 (Yu 2011). Methylation of the
mammalian mRNA export factor ALYREF reduces its RNA-
binding capacity to ensure that the message can be efficiently
displaced by a secondmRNA export factor NXF1 (Hung et al.
2010). However, arginine methylation of FMRP causes
mRNA substrate-speciﬁc changes in RNA binding activity
(Dolzhanskaya et al. 2006). Moreover, arginine methylation
was shown to decrease the capacity of RBP16 to associate
with gRNA. This is not a general effect on RBP16 RNA bind-
ing, however, since methylation conversely increases the as-
sociation of the protein with mRNA (Goulah and Read
2007). In the case of SFPQ/PSF, it is clear that arginine meth-
ylation increases its association with mRNA.
Citrullination of SFPQ/PSF in vitro was demonstrated to
block arginine methylation in vitro. Moreover, citrullination
of SFPQ/PSF by PADI4 in mammalian cells results in de-
creased association with poly(A)+/mRNA. It has previously
been shown that the ribosomal protein S2 (RPS2) is citrul-
linated by PADI4 at an RG repeat region of RPS2, which is
also methylated by protein arginine methyltransferase 3
(PRMT3) (Guo et al. 2011). Therefore, it is likely that the
crosstalk between citrullination and methylation is a wide-
spread phenomenon in RNA binding proteins (RGG re-
peats). This crosstalk may act as a cellular mechanism for
post-translational regulation due to the antagonistic nature
of the modifications and play an important role in mRNP
dynamics.
MATERIALS AND METHODS
Chemicals
Acetonitrile (LC MS grade), water (HPLC grade), formic acid (FA,
HPLC grade) trifluoroacetic acid (TFA, HPLC grade), and ammoni-
um formate (MS grade) were obtained from Thermo Scientific.
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HeLa cell nuclear extracts
HeLa cell nuclear extract (5.0 × 109, Cat. no. CC-01-20-50) was ob-
tained from Cilbiotech. This extract was treated with complete pro-
tease inhibitor cocktail (Roche), divided into 200 µL aliquots and
stored at−80°C. Fifty microliters (≈250 µg) of the HeLa cell nuclear
extract was routinely added to 550 µL PBS and passed through the
open tube capillary as described below.
Open tube capillary (OTC) enrichment
The OTC enrichments were performed essentially as previously de-
scribed (Hanna et al. 2006; Qureshi et al. 2013). Briefly, the sample
was loaded onto a PhyCap IMAC open-tube capillary (PhyNexus),
and the open end submerged in 500 μL wash buffer (PBS + 10 mM
imidazole, pH 7.4). This buffer was drawn into and expelled from a
1 mL disposable syringe at a rate of 150 μL/min, for one draw/expel
cycle. For elution 2–15 μL of desorption buffer (PBS + 250 mM im-
idazole, pH 7.4) was used to the entire elution volume to be main-
tained as a single liquid segment the elution segment was then
pushed back to the bottom of the column at 30 μL/min and was
not allowed to be expelled through the column opening. Upon com-
pletion of the elution cycling, the liquid segment was expelled from
the capillary and collected for analyses.
FLAG-SFPQ purification
One 15-cm plate of 293T cells was transfected using calcium phos-
phate with p3X-FLAG-SFPQ and lysed after 48 h in 500 mL lysis
buffer (PBS, 1% Triton X-100) supplemented with 2 mM PMSF
(Sigma) and complete protease inhibitor (Roche). Cell debris was
removed by centrifugation (16.1 rcf, 10 min, 4°C) and the superna-
tant incubated for 3 h at 4°C with 30 μL α-FLAG M2-agarose slurry
(Sigma) preequilibrated overnight in lysis buffer containing 1% BSA
(Sigma). Beads were then washed (3× bead volume) with PBS, 1 M
NaCl, 0.5% Triton X-100 and TBS (50 mM Tris, pH 7.4, 150 mM
NaCl). Purified protein was eluted in 50 μL 1 × TBS containing
100 mg/mL 3X-FLAG peptide (Sigma) for 30 min at 4°C, before
analysis by SDS-PAGE (stained with Coomassie blue).
Coexpression of FLAG-SFPQ and HA-PADI4
One 15-cm plate of 293T cells was transfected using calcium phos-
phate with p3X-FLAG-SFPQ and pcDNA3.1-HA PADI4 and lysed
after 48 h in 500 mL lysis buffer (1 PBS, 1% Triton X-100) supple-
mented with 2 mM PMSF (Sigma) and complete protease inhibitor
cocktail (Roche). FLAG-SFPQ purification was performed as de-
scribed above.
In vitro methylation reaction
Histidine and GST tagged SFPQ was purified from Escherichia
coli. Recombinant GST-PRMT enzymes were overexpressed from
pGEX6P constructs at 30°C in LB media by addition of 0.1 mM
IPTG and purified using glutathione agarose resin (Pierce).
Enzymes were eluted using 20 mM reduced glutathione then dia-
lyzed against 10% glycerol in 50 mM Tris–HCl, pH 8.0. Arginine
methylation reactions using recombinant SFPQ, endogenous SFPQ
or SFPQ that had been citrullinated in vitro (see below) as substrates,
were carried out with bead-bound PRMTs in 50 mM Tris–HCl, pH
9.0, 5 mM MgCl2, 4 mM dithiothreitol and complete protease in-
hibitor cocktail (Roche) by the addition of 2 μL 3H-AdoMet
(PerkinElmer, 67 Ci/mmol) at 30°C for 1 h. Recombinant GST-
PRMTenzymeswere assayed for activity usingGARas a positive con-
trol substrate (data not shown). Reaction products were denatured
and resolved on 8% SDS-PAGE and electro-transferred to PVDF
membrane. Autoradiography was then performed overnight at
−80°C using a Kodak intensifying screen (Thermo Scientific).
In vitro deimination reaction
Purificationof recombinantGST-PADI4and invitrodeimination as-
says were carried out essentially as described (Cuthbert et al. 2004).
Briefly, GST-PADI4 was overexpressed from a pGEX6P construct
at 30°C in 2TY broth by the addition of 0.1 mM IPTG and purified
using glutathione agarose resin (Thermo Scientific). Deimination re-
actionswere carried out using bead-boundPADI4 in 50mMTris, pH
7.5, 2 mMDTT and complete protease inhibitor cocktail (Roche), in
the presence or absence of 2 mM CaCl2 at 30°C for 1 h.
Coimmunoprecipitation assays
2 × 10-cm HEK 293T plates were used for each condition and were
treated when indicated with 20 µMAdOx or 100 µM AMI-1 for 15 h
prior and during transfections (48 h) or with calcium ionophore for
15 min by adding 4 µM Ca2+ ionophore (Sigma A23187) and 5 mM
CaCl2 to the culture medium. Fifteen microgram plasmid(s) were
transfected per plate with either 15 µg FLAG or 7.5 µg FLAG-
SFPQ + 7.5 µg, FLAG or 7.5 µg FLAG-SFPQ + 7.5 µg PADI4. PBS-
washed cells were lysed in 1mL IP lysis buffer per plate supplemented
with 2 mM PMSF and complete protease inhibitor cocktail (Roche).
Total protein extracts (1.5 mg) were subjected to α-FLAG immuno-
precipitation in the presence or absence of 10 µg RNase Awith 30 µL
FLAG-M2 beads (Sigma) for 1.5 h at 4°C. Beads were then washed
three times with 900 µL IP lysis buffer and protein complexes
were eluted from the beads in 60 µL IP lysis buffer containing
100 μg/mL 3× FLAG peptide for 30min at 4°C. Twelvemicroliter in-
put (∼25 µg) or eluted binding reactions were analyzed by 10% SDS-
PAGE.Whole-cell soluble extracts were subjected to α-FLAG immu-
noprecipitation and analyzed by 12% SDS-PAGE and Western
immunoblotting using α-FLAG (1/5000), α-ALYREF (1/3000),
α-Chtop (KT64—1/2000), or α-Tubulin (1/5000) antibodies.
RNA binding assay
2 × 6-cm 293T plates transfected with either 6 mg of p3X-FLAG,
p3X-FLAG-SFPQ, or p3X-FLAG-ALYREF for each condition were
cross-linked (+UV 0.3 J/cm2) or not (−UV) in 500 mL PBS. Cells
from 2 × 6-cm plates were lysed in 1 mL IP lysis buffer (50 mM
HEPES, pH 7.5/100 mM NaCl/1 mM EDTA/0.5% Triton X-100/
10% glycerol) and cleared total extracts were treated with 200 mL
2 M NaCl to disrupt transient protein–protein interactions.
Purified complexes bound to beads were treated with 10 μg
RNAse A for 15min at 37°C prior to elution under native conditions
using FLAG peptides. Eluted protein/nucleic acids complexes were
labeled with γ32P-ATP and polynucleotide kinase (PNK) and subse-
quently analyzed on SDS-PAGE (stained with Coomassie blue) and
phosphoroImaging.
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mRNP capture assay
PBS-washed transfected 293T cells were UV-irradiated or not on
ice with 0.120 J/cm2 and mRNP capture assays were performed un-
der denaturing conditions as described in Hung et al. (2010).
Complexes were directly eluted in 50 μL elution buffer (10 mM
Tris, pH 7.5, 1 mM EDTA, 0.4 mg/mL RNase A). Captured
mRNA-binding protein complexes were analyzed by SDS-PAGE
and Western blotting.
Increased expression of FLAG-SFPQ following
citrullination
1 × 6-cm HEK 293T plate transfected with p3X-FLAG/p3X-FLAG-
SFPQ, and pcDNA3.1-HA PADI4were treated or not with Ca2+ ion-
ophore for 15 min by adding 4 µM Ca2+ ionophore (Sigma A23187)
and 5 mMCaCl2 to the culture medium. Of note, 100 μM cyclohex-
imide was added for 6 h to block de novo protein synthesis. PBS-
washed cells were lysed in 200 μL IP lysis buffer per plate supple-
mented with 2 mM PMSF and complete protease inhibitor cocktail
(Sigma). Whole-cell extracts were analyzed by 12% SDS-PAGE and
Western immunoblotting using α-FLAG (1/5000), α-ALYREF (1/
3000), α-Chtop (KT64—1/2000), or α-Tubulin (1/5000) antibodies.
Protein digestions
Following purification, SFPQ/NONO complex was digested with
trypsin (Sigma, proteomics grade, 0.1–200 ng) in 100 mM ammoni-
um bicarbonate, 20% acetonitrile at 37°C for 1–6 h. The reactions
were quenched by the addition of 0.1% TFA. The samples were sub-
sequently dried under vacuum and resuspended in 0.1% final con-
centration of TFA. Six microliters were analyzed by LC-MS/MS
analysis.
LC-MS/MS analysis
Tryptic peptides were identified and characterized by using nano-
flow liquid chromatography coupled to mass spectrometry. The
systems used were a Dionex Ultimate 3000 LC system (Thermo
Scientific) with both HCT Ultra PTM Discovery and Maxis
UHR-TOF mass spectrometers (Bruker Daltonics), and a Dionex
Ultimate 3000 RSLCnano LC system (Thermo Scientific) with an
LTQ Orbitrap Velos Pro mass spectrometer (Thermo Scientific).
The peptides were separated on a PepMap C18 reverse phase column
(75 μm× 15 cm, Thermo Scientific) by a linear gradient from 95%
solvent A (0.1% formic acid) to 40% solvent B (0.1% formic acid in
95% acetonitrile) over 40 min at 300 nL/min. Mass spectra were ac-
quired with automated precursor ion selection, using collisionally
induced and electron transfer dissociation for MS/MS, either sepa-
rately or in alternating scans as appropriate for the instrument. Data
sets were converted toMascot Generic Files using scripts supplied by
Bruker and searched against the Swiss-Prot database (Release 10.5,
20 April 2010) with Mascot Server 2.2 (Matrix Science). For meth-
ylation experiments, methionine oxidation, arginine methylation,
and arginine dimethylation were set as variable modifications while
for citrullination, methionine oxidation, and asparagine/glutamine/
arginine deamidation were selected.
Chemical crosslinking
Samples were prepared using PhyCap open-tube capillary methods
described above. Eluted proteins were microdialyzed against PBS
for 20 min to remove imidazole. Crosslinking reagents bis(sulfo-
succinimidyl) suberate (BS3, Pierce) was dissolved in DMSO and
working dilutions were made using ddH2O. A crosslinker was add-
ed at a final concentration of 1 mM and allowed to react for 30 min
at 37°C, before quenching with Tris–HCl, pH 8.0 at a final concen-
tration of 10 mM. For crosslinking using deuterated reagents, bis
(sulfosuccinimidyl) suberate BS3-d0 and BS
3-d4 were dissolved in
DMSO and mixed in a 1:1 molar ratio. Working dilutions were
made and the reaction was carried out as described above.
Crosslinked samples were analyzed by 7.5% SDS-PAGE and excised
for MS analysis.
SUPPLEMENTAL MATERIAL
Supplemental material is available for this article.
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